Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine E Kang

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 2, 2010
Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery systemCatherine E Kang, Charles H Tator, Molly S Shoichet
Journal of Biomedical Materials Research. Part A|October 14, 2004
Cellular alignment by grafted adhesion peptide surface density gradientsCatherine E Kang, Ernest J Gemeinhart, Richard A Gemeinhart
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 28, 2009
Accelerated release of a sparingly soluble drug from an injectable hyaluronan-methylcellulose hydrogelYuanfei Wang, Yakov Lapitsky, Catherine E Kang, et al.
Tissue Engineering. Part A|November 11, 2008
A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repairCatherine E Kang, Peter C Poon, Charles H Tator, et al.
Biomaterials|July 27, 2010
Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injuryM Douglas Baumann, Catherine E Kang, Charles H Tator, et al.
Cells, Tissues, Organs|July 17, 2012
Localized and sustained delivery of fibroblast growth factor-2 from a nanoparticle-hydrogel composite for treatment of spinal cord injuryCatherine E Kang, M Douglas Baumann, Charles H Tator, et al.
Journal of Neurotrauma|August 31, 2010
Spinal cord blood flow and blood vessel permeability measured by dynamic computed tomography imaging in rats after localized delivery of fibroblast growth factorCatherine E Kang, Richard Clarkson, Charles H Tator, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 16, 2009
An injectable drug delivery platform for sustained combination therapyM Douglas Baumann, Catherine E Kang, Jason C Stanwick, et al.
Progress in Histochemistry and Cytochemistry|August 19, 2008
Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosisIris Kulbatski, Andrea J Mothe, Ann M Parr, et al.
Biomaterials|March 31, 2012
The effects of intrathecal injection of a hyaluronan-based hydrogel on inflammation, scarring and neurobehavioural outcomes in a rat model of severe spinal cord injury associated with arachnoiditisJames W Austin, Catherine E Kang, M Douglas Baumann, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 2, 2010
Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery systemCatherine E Kang, Charles H Tator, Molly S Shoichet
Journal of Biomedical Materials Research. Part A|October 14, 2004
Cellular alignment by grafted adhesion peptide surface density gradientsCatherine E Kang, Ernest J Gemeinhart, Richard A Gemeinhart
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 28, 2009
Accelerated release of a sparingly soluble drug from an injectable hyaluronan-methylcellulose hydrogelYuanfei Wang, Yakov Lapitsky, Catherine E Kang, et al.
Tissue Engineering. Part A|November 11, 2008
A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repairCatherine E Kang, Peter C Poon, Charles H Tator, et al.
Biomaterials|July 27, 2010
Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injuryM Douglas Baumann, Catherine E Kang, Charles H Tator, et al.
Cells, Tissues, Organs|July 17, 2012
Localized and sustained delivery of fibroblast growth factor-2 from a nanoparticle-hydrogel composite for treatment of spinal cord injuryCatherine E Kang, M Douglas Baumann, Charles H Tator, et al.
Journal of Neurotrauma|August 31, 2010
Spinal cord blood flow and blood vessel permeability measured by dynamic computed tomography imaging in rats after localized delivery of fibroblast growth factorCatherine E Kang, Richard Clarkson, Charles H Tator, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 16, 2009
An injectable drug delivery platform for sustained combination therapyM Douglas Baumann, Catherine E Kang, Jason C Stanwick, et al.
Progress in Histochemistry and Cytochemistry|August 19, 2008
Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosisIris Kulbatski, Andrea J Mothe, Ann M Parr, et al.
Biomaterials|March 31, 2012
The effects of intrathecal injection of a hyaluronan-based hydrogel on inflammation, scarring and neurobehavioural outcomes in a rat model of severe spinal cord injury associated with arachnoiditisJames W Austin, Catherine E Kang, M Douglas Baumann, et al.
Pageof 2